Showing results (201-210 of 359) with videos related to
Sort By:
Pageof 36
Spine|September 2, 2008
The reproducibility of quantitative measurements in lumbar magnetic resonance imaging of children from the general populationY Masharawi, P Kjaer, T Bendix, et al.Cells|December 22, 2023
Trans-Regulation of Alternative PD-L1 mRNA Processing by CDK12 in Non-Small-Cell Lung Cancer CellsTrine V Larsen, Christoffer T Maansson, Tina F Daugaard, et al.Acta Neurochirurgica. Supplementum|January 1, 1993
Comparison between radiosurgery and stereotactic fractionated radiation for the treatment of brain metastasesA A De Salles, M Hariz, C L Bajada, et al.Stroke|January 1, 1983
Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative studyP S Sorensen, H Pedersen, J Marquardsen, et al.Chest|February 3, 2016
Pleural Effusions at First ED Encounter Predict Worse Clinical Outcomes in Patients With PneumoniaNathan C Dean, Paula P Griffith, Jeffrey S Sorensen, et al.Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancerBritta Weber, Henrik Hager, Boe S Sorensen, et al.Scandinavian Journal of Clinical and Laboratory Investigation|March 1, 2016
Ultra-micro samples can be used for mRNA quantification of lung cancer biomarkersBirgitte Sandfeld-Paulsen, Christina Demuth, Birgitte H Folkersen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2002
Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)K Schreiber, A B Otura, L P Ryder, et al.BMC Cancer|April 30, 2014
Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assaysBritta Weber, Peter Meldgaard, Henrik Hager, et al.Oncogenesis|April 4, 2017
MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cellsK R Jakobsen, C Demuth, A T Madsen, et al.Pageof 36